AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Food Science Article
PDF (4.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Postbiotics Regulate Intestinal Microbiota and Reduce Amyloid β-Protein Deposition in the Brain, Thereby Ameliorating Cognitive Impairment in Rats with Alzheimer’s Disease

Ling XIAO1 Linlin TANG1Xiaoyan SONG1Yihua ZHANG1Xuemei HAN2Houjiao LÜ2Wu LIANG2Yanping WANG1Weitao GENG1Longgang JIA1 ( )
Tianjin Key Laboratory of Food Quality and Health, College of Food Science and Engineering, Tianjin University of Science and Technology, Tianjin 300457, China
Tianjin Key Laboratory of Edible Probiotics, Tianjin InnoOrigin Biological Biotechnology Co., Ltd., Tianjin 300301, China
Show Author Information

Abstract

This study aimed to investigate the impact of three postbiotics at different doses on cognitive function in a rat model of Alzheimer’s disease (AD) induced by D-galactose combined with AlCl3. Specific pathogen-free (SPF) Wistar rats were randomly divided into nine groups: control (Ctrl), AD model, positive drug (donepezil hydrochloride), low-dose (108 CFU/kg) and high-dose (109 CFU/kg) Bifidobacterium animalis spp. lactis IOBL07, Lactiplantibacillus plantarum IOB602 and L. paracasei IOB413. The Ctrl group was intraperitoneally and orally administered with normal saline, while all other experimental groups were subjected to intraperitoneal injection of D-galactose and oral gavage of AlCl3. The model induction period lasted for 13 consecutive weeks. At 1 h following the last injection and oral gavage, the intervention groups were orally administered with donepezil hydrochloride or postbiotics, whereas the Ctrl and AD groups were given an equivalent volume of normal saline. The Morris water maze was used to assess the learning and memory capacities of the rats in each group. Additionally, the content and immunofluorescence intensity of amyloid β-protein (Aβ) in hippocampal tissues were determined. Histopathological changes in the small intestine were examined along with changes in the intestinal microbiota. The levels of lipopolysaccharide (LPS) in feces, serum, and hippocampal tissues were determined as well as the relative mRNA transcription levels of Toll-like receptor 4 (TLR4), NOD-like receptor thermal protein domain associated protein 3 (NLRP3) and myeloid differentiation factor 88 (MyD88) in brain tissues. The results showed that all three postbiotics could significantly improve the learning and memory capacities of AD rats, significantly reduce the content of Aβ in hippocampal tissues, and decrease the LPS levels in feces, serum, and hippocampal tissues and the relative mRNA transcription levels of TLR4, NLRP3 and MyD88 in brain tissues. Intervention with the postbiotics regulated the structure and composition of the intestinal microbiota. In the postbiotic intervention groups, the relative abundance of the predominant intestinal bacteria, Firmicutes, and the beneficial species, Ruminococcaceae increased, the relative abundance of the potential harmful intestinal bacteria, Muribaculaceae, decreased compared with the AD model group. Thus, the postbiotics IOBL07, IOB602, and IOB413 have significant efficacy in ameliorating memory and cognitive deficits in AD rats, the most pronounced effect being observed with high-dose IOB602. The underlying mechanisms might be associated with regulating the structure and composition of the gut microbiota and down-regulating the relative mRNA transcription levels of TLR4, NLRP3 and MyD88 in brain tissues.

CLC number: TS201.3 Document code: A Article ID: 1002-6630(2025)05-0182-12

References

[1]

SMALL S A, GANDY S. Sorting through the cell biology of Alzheimer’s disease: intracellular pathways to pathogenesis[J]. Neuron, 2006, 52(1): 15-31. DOI:10.1016/j.neuron.2006.09.001.

[2]

AZIZI G, MIRSHAFIEY A. The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis[J]. Immunopharmacology and Immunotoxicology, 2012, 34(6): 881-895. DOI:10.3109/08923973.2012.705292.

[3]

HARDY J A, HIGGINS G A. Alzheimer’s disease: the amyloid cascade hypothesis[J]. Science, 1992, 256(5054): 184-185. DOI:10.1126/science.1566067.

[4]

MANDELKOW E M, MANDELKOW E. Tau in Alzheimer’s disease[J]. Trends in Cell Biology, 1998, 8(11): 425-427. DOI:10.1016/s0962-8924(98)01368-3.

[5]

DETURE M A, DICKSON D W. The neuropathological diagnosis of Alzheimer’s disease[J]. Molecular Neurodegeneration, 2019, 14(1): 32. DOI:10.1186/s13024-019-0333-5.

[6]

KAUR D, SHARMA V, DESHMUKH R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease[J]. Inflammopharmacology, 2019, 27(4): 663-677. DOI:10.1007/s10787-019-00580-x.

[7]

BOLÓS M, PEREA J R, AVILA J. Alzheimer’s disease as an inflammatory disease[J]. Biomolecular Concepts, 2017, 8(1): 37-43. DOI:10.1515/bmc-2016-0029.

[8]

RAJKUMAR M, KANNAN S, THANGARAJ R. Voglibose attenuates cognitive impairment, Aβ aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer’s disease rat model[J]. Inflammopharmacology, 2023, 31(5): 2751-2771. DOI:10.1007/s10787-023-01313-x.

[11]

SALMINEN S, COLLADO M C, ENDO A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics[J]. Nature Reviews Gastroenterology & Hepatology, 2021, 18(9): 649-667. DOI:10.1038/s41575-021-00440-6.

[12]

WEGH C A M, GEERLINGS S Y, KNOL J, et al. Postbiotics and their potential applications in early life nutrition and beyond[J]. International Journal of Molecular Sciences, 2019, 20(19): 4673. DOI:10.3390/ijms20194673.

[13]

HE X L, ZENG Q, PUTHIYAKUNNON S, et al. Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense[J]. Scientific Reports, 2017, 7: 43305. DOI:10.1038/srep43305.

[14]

WANG Y W, WANG D H, LV H J, et al. Modulation of the gut microbiota and glycometabolism by a probiotic to alleviate amyloid accumulation and cognitive impairments in AD rats[J]. Molecular Nutrition & Food Research, 2022, 66(19): e2200265. DOI:10.1002/mnfr.202200265.

[15]

OTHMAN M Z, HASSAN Z, CHE HAS A T. Morris water maze) a versatile and pertinent tool for assessing spatial learning and memory[J]. Experimental Animals, 2022, 71(3): 264-280. DOI:10.1538/expanim.21-0120.

[17]

SCHNEIDER M A, HEEB L, BEFFINGER M M, et al. Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models[J]. Science Translational Medicine, 2021, 13(611): eabc8188. DOI:10.1126/scitranslmed.abc8188.

[21]

HAGERTY S L, HUTCHISON K E, LOWRY C A, et al. An empirically derived method for measuring human gut microbiome alpha diversity: demonstrated utility in predicting health-related outcomes among a human clinical sample[J]. PLoS ONE, 2020, 15(3): e0229204. DOI:10.1371/journal.pone.0229204.

[23]

GRICE E A, KONG H H, CONLAN S, et al. Topographical and temporal diversity of the human skin microbiome[J]. Science, 2009, 324(5931): 1190-1192. DOI:10.1126/science.1171700.

[24]

CLEMENTE J C, URSELL L K, PARFREY L W, et al. The impact of the gut microbiota on human health: an integrative view[J]. Cell, 2012, 148(6): 1258-1270. DOI:10.1016/j.cell.2012.01.035.

[25]

KELLY D, CAMPBELL J I, KING T P, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA[J]. Nature Immunology, 2004, 5(1): 104-112. DOI:10.1038/ni1018.

[26]

BOSTANCIKLIOĞLU M. Intestinal bacterial flora and Alzheimer’s disease[J]. Neurophysiology, 2018, 50(2): 140-148. DOI:10.1007/s11062-018-9728-0.

[27]

CHEUNG S G, GOLDENTHAL A R, UHLEMANN A C, et al. Systematic review of gut microbiota and major depression[J]. Frontiers in Psychiatry, 2019, 10: 34. DOI:10.3389/fpsyt.2019.00034.

[28]

LIU P, WU L, PENG G P, et al. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort[J]. Brain, Behavior, and Immunity, 2019, 80: 633-643. DOI:10.1016/j.bbi.2019.05.008.

[29]

LIU X E, TENG T, LI X M, et al. Impact of inosine on chronic unpredictable mild stress-induced depressive and anxiety-like behaviors with the alteration of gut microbiota[J]. Frontiers in Cellular and Infection Microbiology, 2021, 11: 697640. DOI:10.3389/fcimb.2021.697640.

[31]

SEGATA N, IZARD J, WALDRON L, et al. Metagenomic biomarker discovery and explanation[J]. Genome Biology, 2011, 12(6): R60. DOI:10.1186/gb-2011-12-6-r60.

[32]

BARRETT E, ROSS R P, O’TOOLE P W, et al. γ-Aminobutyric acid production by culturable bacteria from the human intestine[J]. Journal of Applied Microbiology, 2012, 113(2): 411-417. DOI:10.1111/j.1365-2672.2012.05344.x.

[34]

KAYAGAKI N, WONG M T, STOWE I B, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4[J]. Science, 2013, 341(6151): 1246-1249. DOI:10.1126/science.1240248.

[35]

ASCHENBACH J R, ZEBELI Q, PATRA A K, et al. Symposium review: the importance of the ruminal epithelial barrier for a healthy and productive cow[J]. Journal of Dairy Science, 2019, 102(2): 1866-1882. DOI:10.3168/jds.2018-15243.

[37]

XIA W W, LI Y Y, WU M Y, et al. Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation[J]. Cell Death & Disease, 2021, 12(2): 139. DOI:10.1038/s41419-021-03431-2.

Food Science
Pages 182-193
Cite this article:
XIAO L, TANG L, SONG X, et al. Postbiotics Regulate Intestinal Microbiota and Reduce Amyloid β-Protein Deposition in the Brain, Thereby Ameliorating Cognitive Impairment in Rats with Alzheimer’s Disease. Food Science, 2025, 46(5): 182-193. https://doi.org/10.7506/spkx1002-6630-20240818-130

101

Views

7

Downloads

0

Crossref

0

Scopus

0

CSCD

Altmetrics

Received: 18 August 2024
Published: 15 March 2025
© Beijing Academy of Food Sciences 2025.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return